Martin Streeter
Education
Case Western Reserve University School of Medicine
MS, Biometry/Biostatistics -
University of Colorado Boulder
BS, Molecular Biology -Work Experience
StreetStat LLC
Current
StreetStat LLC
Mass Medical Angels
Current
Mass Medical Angels
Drumroll AI
2012-01-01 - 2012-06-01
Drumroll AI
IntelligentMDx
2006-01-01 - 2008-01-01
IntelligentMDx
Zero Stage Capital
2004-06-01 - 2006-06-01
Zero Stage Capital
Parexel
2002-09-01 - 2003-10-01
Parexel
Invantage, Inc.
1995-06-01 - 2002-09-01
Invantage, Inc.
Skills
Summary
Martin brings more than 30 years of international executive deployment of mission critical software systems often in compliance with FDA/EMA regulatory guidelines. He initiated his career as a Biostatistics/database expert on the original Bolt Beranek & Newman (BBN) Clintrial Database software team (back in the early 80's). He got lucky and participated in an angel investment round funding PAREXEL International, (now a multi-billion $ CRO). Along the way he raised >$1M in classic venture capital to launch and operate Invantage, Inc. - an entity focused to create trusted alliances between physicians and industry thereby accelerate and reduce pivotal Phase III drug trial startup costs. Invantage was acquired by Perceptive Informatics in 2002. Over a time-span of 10,000 hours, he built a deep intuitive comprehension of pre-clinical, drug development R&D processes capped via authorship of corporate-wide quality life science control guidelines and standard operating procedures (SOPs). More recently, at Massachusetts Medical Angels (MA2) he has played a key role in sourcing startups, the screening committee and has directed deep-dive due diligence teams looking at early stage Life Science, Healthcare IT and Medical Device investment opportunities.
